Osteoarthritis of the Knee Clinical Trial
Official title:
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study to Evaluate the Efficacy and Safety of X0002 Spray Versus Placebo in Subjects With Osteoarthritis
This is a phase 2, multicenter, randomized, double blind (with dose), placebo controlled,
parallel group, proof of concept, and dose range finding study to evaluate the efficacy,
safety, and PK of X0002 spray in adult subjects with clinically symptomatic mild to moderate
OA of the knee.
Objectives of the study:
1. To evaluate the efficacy of X0002 spray compared to placebo for relief of knee pain in
subjects with osteoarthritis (OA) of the knee;
2. To assess the safety and tolerability of multiple doses of X0002 when administered as a
topical spray.
This is a phase 2, multicenter, randomized, double blind (with dose), placebo controlled,
parallel group, proof of concept, and dose range finding study to evaluate the efficacy,
safety, and PK of X0002 spray in adult subjects with clinically symptomatic mild to moderate
OA of the knee.
After a screening period of up to 3 weeks and radiographic evaluation of the target knee
joint space, 225 subjects will be randomly assigned to 1 of 3 treatment groups in a 1:1:1
ratio with a 2:1 ratio of active:placebo within each treatment group in a 1:1:1 ratio with a
2:1 ratio of active:placebo within each treatment group (i.e., 2 subjects to active treatment
and 1 subject to placebo):
Group A: low dose of X0002, twice daily (BID, approximately every 12 hours; n=50) or placebo
(low dose), BID (approximately every 12 hours; n=25); Group B: middle dose of X0002, BID
(approximately every 12 hours; n=50) or placebo , BID (approximately every 12 hours; n=25) ;
Group C: High dose of X0002, BID (approximately every 12 hours; n=50) or placebo, BID
(approximately every 12 hours; n=25) .
Safety and efficacy assessments will be performed at at 2, 4, 8, and 12 weeks of treatment.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03277066 -
A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis
|
Phase 2 | |
| Recruiting |
NCT03090698 -
Outcomes of Injections in Patients Waiting for Total Knee Replacement
|
Phase 4 | |
| Completed |
NCT02556710 -
A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee
|
Phase 3 | |
| Completed |
NCT02242435 -
A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis
|
Phase 3 | |
| Withdrawn |
NCT02237846 -
Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis
|
Phase 1/Phase 2 | |
| Completed |
NCT02096393 -
Patient Specific Instrumentation in TKR
|
N/A | |
| Completed |
NCT01849445 -
Targeted Rehabilitation to Improve Outcome After Knee Replacement- A Physiotherapy Study
|
N/A | |
| Completed |
NCT01704157 -
A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device
|
N/A | |
| Active, not recruiting |
NCT01374230 -
Long-Term Multicenter Evaluation of the E1® Tibial Bearing
|
N/A | |
| Completed |
NCT02156440 -
Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee
|
Phase 2 | |
| Not yet recruiting |
NCT01270412 -
Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis
|
Phase 2/Phase 3 | |
| Completed |
NCT01410409 -
Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement
|
N/A | |
| Completed |
NCT01207115 -
A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee
|
Phase 2 | |
| Completed |
NCT00970008 -
Exploring Massage Benefits for Arthritis of the Knee
|
Phase 2 | |
| Completed |
NCT00988091 -
Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee
|
Phase 3 | |
| Completed |
NCT01331278 -
A Comparative Study of Knee Systems
|
Phase 4 | |
| Completed |
NCT00792727 -
HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain
|
Phase 3 | |
| Completed |
NCT00531427 -
Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee
|
Phase 3 | |
| Completed |
NCT00449696 -
Gel-200 Versus Placebo in Osteoarthritis of the Knee
|
Phase 3 | |
| Completed |
NCT04145011 -
Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain
|
N/A |